Adenosine therapy: a new approach to chronic heart failure

Bibliography

• HORI M, KITAKAZE M: Adenosine, the heart and coronary. Hypertension (1991) 18:565–574.
   PubMed Web of Science ®Google Scholar
• KITAKAZE M, HORI M, KAMADA T: The role of adenosine and its interaction with a-adrenoceptor activity in myocardial ischemic and rep erfusion injury. Cardiovasc. Res. (1993) 27:18–27.
   PubMed Web of Science ®Google Scholar
• MUBAGWA K, MULLANE K, FLAMENG W: Role of adenosine in the heart and circulation. Cardiovasc. Res. (1996) 32:797–813.
   PubMed Web of Science ®Google Scholar
• LAGERKRANSER N, SOLLEVI A, IRESTEDT L, TIDGREN B, ANDREEN M: Renin release during controlled hypoten-sion with sodium nitroprusside, nitroglycerin and adenosine: A comparative study in the dogs. Acta Anaesthesiol. Scand. (1985) 29:45–49.
   PubMed Web of Science ®Google Scholar
• PARMELY MJ, ZHOU WW, EDWARD CK III, BORCHERDING DR, SILVERSTEIN R, MORRISON DC: Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumour necrotic factor-a production and protect mice against endotoxin challenge. J Immunol (1993) 151:389–396.
   PubMed Web of Science ®Google Scholar
• FISCHER S, KNOLL R, RENZ D, KARLICZEK GF, SCHAPER W: Role of adenosine in the hypoxic induction of vascular endothelial growth factor in porcine brain derived microvascular endothelial cells. Endothelium (1997) 5(4):373.
   Google Scholar
• DUSSEUAU JW, HUTCHINS M, MALBASA DS: Stimulation of angiogenesis by adenosine on the chick choriaoal-lantonic membrane. Circ. Res. (1986) 59:163–170.
   PubMed Web of Science ®Google Scholar
• MEINNGER CJ, SCHELLING ME, GRANGER HJ: Adenosine and hypoxia stimulate proliferation and migration of endothelial cells. Am. J Physiol. (1988) 255:H554–H562.
   PubMed Web of Science ®Google Scholar
• MEINNGER CJ, GRANGER HJ: Mechanisms leading to adenosine-stimulated proliferation of microvascular endothelial cells. Am. J Physiol. (1990) 258:H198–H206.
   PubMed Web of Science ®Google Scholar
• OHISALO JJ: Regulatory functions of adenosine. Med. Biol. (1987) 65:181–191.
   PubMedGoogle Scholar
• ACHTERBERG PW, DE TOMBEP P, HARMSEN E, DE JONG JW: Myocardial S-adenosylhomocysteine hydrolase is important for adenosine production during normoxia. Biochem. Biophys. Acta (1985) 840:393–400.
   PubMed Web of Science ®Google Scholar
• SPARKS HV, JR., BARDENHEUER H: Regulation of adenosine formation in the heart. Circ. Res. (1986) 58:193–201.
   PubMed Web of Science ®Google Scholar
• LLYOD GE, SCHARADER J: The importance of the transmethylation pathway for adenosine metabolism in the heart. In: Topics and Perspectives in Adenosine Research. Gerlach E, Becker BF (Eds.), Springier-Verlag, Berlin Heidelberg, Germany (1987):199–207.
   Google Scholar
• DEUSSEN A, BORST M, SCHRADER J: Formation adenosylhomocysteine in the heart. I: An index intracellular adenosine. Circ. Res. (1988) 63:240–249.
   Google Scholar
• RUBIO R, WIEDMEIER VT, BERNE RM: Relationship between coronary flow and adenosine production and release. j. Mol. Cell Cardiol. (1974) 6:561–566.
   PubMed Web of Science ®Google Scholar
• WADSWORTH RM: The effects of aminophylline on the increased myocardial blood flow produced by systemic hypoxia or by coronary artery occlusion. Eur.J. Pharmacol. (1972) 20:130–132.
   PubMed Web of Science ®Google Scholar
• WEI HM, KANG YH, MERILL GF: Canine coronary vasodepressor response to hypoxia are abolished by 8-phenyltheophylline. Am. J Physiol. (1989) 257 :H1043–H1048.
   PubMed Web of Science ®Google Scholar
• CURNISH RR, BERNE RM, RUBIO R: Effects of aminophyl-line on myocardial reactive hyperemia. Proc. Soc. Exp. Biol. Med. (1972) 141:593–598.
   PubMed Web of Science ®Google Scholar
• MERRILL GF, DOWNEY F, JONES CE: Adenosine deaminase attenuates canine coronary vasodilation during systemic hypoxia. Am. J. Physiol. (1986) 250:H579–H583.
   PubMed Web of Science ®Google Scholar
• WEI HM, KANG YH, MERILL GF: Coronary vasodilationduring global myocardial hypoxia: Effect of adenosine deaminase. Am. J Physiol. (1988) 254:H1004–H1009.
   PubMed Web of Science ®Google Scholar
• RUBIO R, BERNE RM: Regulation of coronary blood flow. Prog. Cardiovasc. Dis. (1975) 8:105–122.
   Google Scholar
• KITAKAZE M, HORI M, TAMAI J et al.: 131-Adreno cep tor activity regulates release of adenosine from the ischemic myocardium in dogs. Circ. Res. (1987) 60:631–639.
   PubMed Web of Science ®Google Scholar
• HORI M, TAMAI J, KITAKAZE M et al: Adenosine-inducedhyperemia attenuates myocardial ischaemia in coronary microembolization in dogs. Am. J Physiol (1989) 257:H244–H251.
   PubMed Web of Science ®Google Scholar
• BUXTON ILO, WALTHER J, WESTFALL DP: Purinergic mechanisms in cardiac blood vessels: Stimulation of endothelial cell a receptors in vitro by the neurotrans-mitter noradrenaline leads to the rapid release of ATP and its subsequent breakdown to adenosine. Heart Vessel (1990) 4 (Suppl.):27. Abstract.
   Google Scholar
• KITAKAZE M, HORI M, MORIOKA T et al.: 131-Adrenoce-p tor activation increases ectosolic 5 t-nucleotidase activity and adenosine release in rat cardiomyocytes by activating protein kinase C. Circulation (1995) 91:2226–2234.
   PubMed Web of Science ®Google Scholar
• KITAKAZE M, MINAMINO T, NODE K et al.: Activation ofecto-5t-nucleotidase by protein kinase C attenuates irreversible cellular injury due to hypoxia and reoxygenation in rat cardiomyocytes. j Mol. Cell Cardiol. (1996) 28:1945–1955.
   PubMed Web of Science ®Google Scholar
• HERMANN SC, FEIGL EO: Adrenergic blockade bluntsadenosine concentration and coronary vasodilation during hypoxia. Circ. Res. (1992) 70:1203–1216.
   PubMed Web of Science ®Google Scholar
• LONDOS C, WOLFF J: Two distinct adenosine-sensitivesites on adenyl cyclase. Proc. Natl. Acad. ScL USA (1977) 74:5482–5486.
   PubMed Web of Science ®Google Scholar
• LONDOS C, COOPER DMF, SCHLEGEL W, RODBELL M: Adenosine analogs inhibit adipocyte adenyl cyclase by a GTP-dependent process: Basis for actions of adenosine and methylxanthines on cyclic AMP production and lipolysis. Proc. Natl. Acad. ScL USA (1978) 75:5362–5366.
   PubMed Web of Science ®Google Scholar
• OLSSON RA, PEARSON JD: Cardiovascular purinocep-tors. Physiol. Rev. (1990) 70:761–845.
   PubMed Web of Science ®Google Scholar
• DEGENRING FH: The effect of acidosis and alkalosis oncoronary flow and cardiac nucleotide metabolism. Basic Res. Cardiol. (1976) 71:287–290.
   PubMed Web of Science ®Google Scholar
• HORI M, KITAKAZE M, TAMAI J et al.: 132-Adrenocep tor stimulation can augment coronary vasodilation maximally induced by adenosine in dogs. Am. J. Physiol. (1989) 257:H132–H140.
   PubMed Web of Science ®Google Scholar
• HORI M, KITAKAZE M, TAMAI J et al.: 132-Adrenocep tor activity exerts dual control of coronary blood flow in canine coronary artery. Am. J. Physiol. (1988) 255:H250–H260.
   PubMed Web of Science ®Google Scholar
• KITAKAZE M, HORI M, GOTOH K et al.: Beneficial effectsof 132-activity on ischemic myocardium during coronary hypoperfusion in dogs. Circ. Res. (1989) 65:1632–1645.
   PubMed Web of Science ®Google Scholar
• NAYLER WG, PRICE JM, LOWE TE: Inhibition of adenosine-induced coronary vasodilation. Cardiovasc. Res. (1967) 1:63–66.
   PubMedGoogle Scholar
• BELARDINELLI L, ISENBERG G: Actions of adenosine andisoproterenol on isolated mammalian ventricular myocytes. Circ. Res. (1983) 53:287–297.
   PubMed Web of Science ®Google Scholar
• SATO H, HORI M, KITAKAZE M et al: Endogenous adenosine attenuates 13-adrenoceptor-mediated inotropic response in the hypop er fused canine myocardium. Circulation (1992) 85: 1594-1603.
   Google Scholar
• ISENBERG G, BELARDINELLI L: Ionic basis for theantagonism between adenosine and isoproterenol on isolated mammalian ventricular myocytes. Circ. Res. (1984) 55:309–325.
   PubMed Web of Science ®Google Scholar
• ISENBERG G, CERBAI E, KLOCKNER U: Ionic channelsand adenosine in isolated heart cells. In: Topics and Perspective in Cardiovascular Research. Gerlach E, Becker BF (Eds.), Springer-Verlag, Berlin, Germany (1987):323–335.
   Google Scholar
• TADDEI S, ARZILLI F, ARRIGHI P, SALVETTI A: Dipyrida-mole decreases circulating renin-angiotensin system activity in hypertensive patients. Am. J Hypertens. (1992) 5:29–31.
   PubMed Web of Science ®Google Scholar
• RICHARDT G, WASSA W, KRANZHOFER R, MAYER E, SCHOMING A: Adenosine inhibits ex ocytotic release of endogenous noradrenaline in rat heart: A protective mechanism in early myocardial ischaemia. Circ. Res. (1987) 61:117–123.
   PubMed Web of Science ®Google Scholar
• CRONSTEIN BN, LEVIN RI, BELANOFF J, WEISSMANN G,HIRSCHHORN R: Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. J Clin. Invest. (1986) 78:760–770.
   PubMed Web of Science ®Google Scholar
• CRONSTEIN BN, KRAMER SB, WEISSMANN G, HIRSCH-HORN R: Adenosine: a physiological modulator of superoxide anion generation by human neutrophils. Exp. Med. (1986) 158:1160–1177.
   Google Scholar
• CRONSTEIN BN: Adenosine is an autacoid of inflamma-tion: Effects of adenosine on neutrophil function. In: Role of Adenosine and Adenine Nucleotides in the Biological System. Imai S, Nakazawa M (Eds.), Elsevier Science Publisher, Amsterdam, Netherlands (1991):515–520.
   Google Scholar
• KITAKAZE M, HORI M, MORIOKA T et at: Attenuation ofSt-nucleotides and adenosine release in activated human polymorphonuclear leukocytes. Circ. Res. (1993) 73:524–533.
   PubMed Web of Science ®Google Scholar
• STEENBERGEN C, PERLMAN ME, LONDON RE, MURPHY E:Mechanism of preconditioning. Ionic alterations. Circ. Res. (1993) 72:112–125.
   PubMed Web of Science ®Google Scholar
• WAGNER DR, MCTIERNAN C, SANDERS VJ, FELDMAN AM:Adenosine inhibits lipopolysaccharide-induced secretion of tumour necrosis factor-a in the failing human heart. Circulation (1998) 97:521–524.
   PubMed Web of Science ®Google Scholar
• AGARWAL KC: Adenosine and platelet function. In: Roleof Adenosine in Cerebral Metabolism and Blood Flow. Stefanovich V, Okayuz-Baklouti I (Eds.), VNU Science Press, Utrechit, Netherlands (1987):107–124.
   Google Scholar
• KITAKAZE M, HORI M, SATO H et al.: Endogenousadenosine inhibits platelet aggregation during myocardial ischaemia in dogs. Circ. Res. (1991) 69:1402–1408.
   PubMed Web of Science ®Google Scholar
• MINAMINO T, KITAKAZE M, ASANUMA H et al.: Endoge-nous adenosine inhibits P-selectin -dep en dent formation of coronary thrombi duringhypoperfusion in dogs. J. Clin. Invest. (1998) 101:1643–1653.
   PubMed Web of Science ®Google Scholar
• KURTZ A: Adenosine stimulates guanylate cyclase activity in vascular smooth muscle cells. J Biol. Chem. (1987) 262:6296–6300.
   PubMed Web of Science ®Google Scholar
• VAN SCHAICK EA, JACOBSON KA, KIM HO, IJZERMAN AP,DANHOF M: Hemodynamic effects and histamine release elicited by the selective adenosine A3 receptor agonist 2-C1-IB-MECA in conscious rats. Eur. J. Pharmacol. (1996) 308:311–314.
   PubMed Web of Science ®Google Scholar
• BRUNS RF, LU GH, PUGSLEY TA: Characterization of theA2 adenosine receptor labeled by PHINECA in rat striatal membranes. Mot. Pharmacol (1986) 29:331–346.
   PubMed Web of Science ®Google Scholar
• HARDER DR, BELARDINELLI L, SPERELAKIS N, RUBIO R,BERNE RM: Differential effects of adenosine and nitroglycerin on the action potential of large and small coronary arteries. Circ. Res. (1979) 44:176–182.
   PubMed Web of Science ®Google Scholar
• FENTON RA, RUBIO BR, BERNE AM: Effect of adenosineon calcium uptake by intact and cultured vascular smooth muscle. Am. J Physiol. (1982) 242:H797–H804.
   PubMed Web of Science ®Google Scholar
• AVERSANO T, OUYANG P, SILVERMAN H: Blockade ofthe ATP-sensitive potassium channel modulate reactive hyperemia in the canine circulation. Circ. Res. (1991) 69:618–622.
   PubMed Web of Science ®Google Scholar
• NEES S, HERZOG V, BECKER BF, BOCK M, ROSIERS CD,GERLACH E: The coronary endothelium: a highly active metabolic barrier for adenosine. Basic Res. Cardiol (1985) 80:515–529.
   PubMed Web of Science ®Google Scholar
• MATSUDA H, IMAI S: Effects of adenosine and adenine nucleotides on the diameter of the isolated perfused pig coronary artery. Jpn. j Pharmacol. (1990) 52 (Suppl. II):116. Abstract.
   Google Scholar
• MINAMINO, KITAKAZE M, MATSUMURA Y et al.: Impacts of coronary risk factors on contributions of metabolic coronary vasodilation in humans. J. Am. Coll Cardiol (1998) 31:1274–1279.
   PubMed Web of Science ®Google Scholar
• MOSQUEDA-GARCIA R, TSENG CJ, APPALSAMY M, ROBERTSON D: Modulatory effects of adenosine on baroreflex activation in the brainstem of normoten-sive rats. Eur.j Pharmacol (1989) 174:119–122.
   PubMed Web of Science ®Google Scholar
• KITAKAZE M, MINAMINO T, NODE K et al.: Adenosineand cardioprotection in the diseased heart. Jpn. Circ. J. (1999) 63:231–243.
   PubMedGoogle Scholar
• KITAKAZE M, HORI M: It is time to ask what adenosinecan do for cardioprotection. Heart Vessels (1998) 13:211–228.
   PubMed Web of Science ®Google Scholar
• KITAKAZE M: It is the time to ask what adenosine cando for cardioprotection in ischemic heart disease. Int. Med. (1999) 38:305–306.
   PubMed Web of Science ®Google Scholar
• WATANABE E, SMITH DM, SUN J et al.: Effect of basic fibroblast growth factor on angiogenesis in the in far cted porcine heart. Basic Res. Cardiol. (1998) 93:30–37.
   PubMed Web of Science ®Google Scholar
• SCHAPER W: Angiogenesis in the adult heart. Basic Res. Cardiol. (1991) 86 (Suppl. 2):51–56.
   Google Scholar
• LOSORDO DW, VALE PR, SYMES JF et al: Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischaemia. Circulation (1998) 98:2800–2804.
   PubMed Web of Science ®Google Scholar
• YANAGISAWA MA, UCHIDA Y, NAKAMURA F et al.: Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science (1992) 257:1401–1403.
   PubMed Web of Science ®Google Scholar
• HIRASHIMA M, KATAOKA H, NISHIKAWA S, MATSUYOSHI N, NISHIKAWA SI: Maturation of embryonic stem cells into endothelial cells in an In vitro model of vasculogenesis. Blood (1999) 93(4):1253–1263.
   PubMed Web of Science ®Google Scholar
• SYMONS JD, FIROOZMAND E, LONGHURST JC: Repeateddipyridamole administration enhances collateral-dependent flow and regional function during exercise. A role for adenosine. Circ. Res. (1993) 73:503–513.
   PubMed Web of Science ®Google Scholar
• MURRY, CE, JENNINGS RB, REIMER KA: Preconditioning with ischaemia: A delay of lethal cell injury in ischemic myocardium. Circulation (1986) 74:1124–1136.
   PubMed Web of Science ®Google Scholar
• LIU GS, THORNTON J, VAN WINKLE DM, STANLEY AWH, OLSSON RA, DOWNEY JM: Protection against infarction afforded by preconditioning is mediated by Ai adenosine receptors in rabbit heart. Circulation (1991) 84:350–356.
   PubMed Web of Science ®Google Scholar
• KITAKAZE M, HORI M, MORIOKA T et al.: The infarctsize-limiting effect of ischemic preconditioning is blunted by inhibition of 5'-nucleotidase activity and attenuation of adenosine release. Circulation (1994) 89:1237–1246.
   PubMed Web of Science ®Google Scholar
• MITCHELL MB, MENG X, AO L, BROWN JM, HARKEN AH, BANERJEE A: Preconditioning of isolated rat heart is mediated by protein kinase C. Circ. Res. (1995) 76:73–81.
   PubMed Web of Science ®Google Scholar
• KITAKAZE M, NODE K, MINAMINO T et al.: The role of activation of protein kinase C in the infarct size-limiting effect of ischemic preconditioning through activation of ecto -5 t-n ucleo tidas e. Circulation (1996) 93:781–791.
   PubMed Web of Science ®Google Scholar
• KITAKAZE M, FUNAYA H, MINAMINO T et al.: Role of Protein Kinase C-a in activation of ecto-5t-nucleotidase in the preconditioned canine myocardium. Biochem. Biophys. Res. Commun. (1997) 239:171–175.
   PubMed Web of Science ®Google Scholar
• TSUCHIDA AM LIU Y, LIU GS, COHEN MV, DOWNEY JM: N-Adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ. Res. (1994) 75:576–585.
   PubMed Web of Science ®Google Scholar
• ARMSTRONG S, GANOTE CE: In vitroischaemic precon-ditioning of isolated rabbit cardiomyocytes: Effect of selective adenosine receptor blockade and calphostin C. Cardiovasc. Res. (1995) 29:647–652.
   PubMed Web of Science ®Google Scholar
• MARBAR MS, LATCHMAN DS, WALKER JM, YELLON DM: Cardiac stress protein elevation 24 h after brief ischaemia or heat stress associated with resistance to myocardial infarction. Circulation (1993) 83:13–25.
   Google Scholar
• KUZUYA T, HOSHIDA S, YAMASHITA N et al.: Delayed effects of sublethal ischaemia on the acquisition of tolerance to ischaemia. Circ. Res. (1993) 72:1293–1299.
   PubMed Web of Science ®Google Scholar
• SUZUKI K, SAWA Y, KANEDA Y, ICHIKAWA H, SHIRAKURA R, MATSUDA H: In vivo gene transfection with heat shock protein 70 enhances myocardial tolerance to ischaemia-reperfusion injury in rat. J Clin. Invest. (1997) 99:1645–1650.
   PubMed Web of Science ®Google Scholar
• SAKAGUCHI T, SAWA Y, MISAHIMURA M et al.: Ecto-5t-nucleotidase activated by heat shock protein 70 attenuates ischaemia and reperfusion injury in myocardium. Evidence for a mechanism of second window protection. Circulation (1998) 98:1–527.
   Google Scholar
• KITAKAZE M, HORI M, TAKASHIMA S et al.: Superoxidedismutase enhances ischaemia-induced reactive hyperemic flow and adenosine release in dogs: A role of 5t-nucleotidase activity. Circ. Res. (1992) 71:558–566.
   PubMedGoogle Scholar
• DANA A, JONASSEN AK, YAMASHITA N, YELLON DM: Adenosine A(1) receptor activation induces delayed preconditioning in rats mediated by manganese superoxide dismutase. Circulation (2000) 101:2841–2848.
   PubMed Web of Science ®Google Scholar
• KITAKAZE M, TAKASHIMA S, SATO H: Stimulation ofadenosine Ai and A2 receptors prevents myocardial stunning. Circulation (1990) 82:111-37. Abstract.
   Google Scholar
• KITAKAZE, M, HORI M, SATO H et al.: Beneficial effectsof 131-adrenocep tor activity on myocardial stunning in dogs. Circ. Res. (1991) 68:1322–1339.
   PubMed Web of Science ®Google Scholar
• KITAKAZE M, WEISMAN HF, MARBAN E: Contractile dysfunction and ATP depletion after transient calcium overload in perfused ferret hearts. Circulation (1988) 77:685–695.
   PubMed Web of Science ®Google Scholar
• MARBAN E, KITAKAZE M, KORETSUNE Y, YUE DT, CHACKO VP, PIKE MM: Quantification of ra2li in perfused hearts. Critical evaluation of the 5F-BAPTA and nuclear magnetic resonance method as applied for the study of ischaemia and reperfusion. Circ. Res. (1990) 66:1255–1267.
   Google Scholar
• HORI M, INOUE M, KITAKAZE M et al.: Role of adenosinein hyperemic response of coronary blood flow in microembolization. Am. J. Physiol. (1986) 250:H509–H518.
   PubMed Web of Science ®Google Scholar
• HORI M, GOTOH K, KITAKAZE M et al.: Role of oxygen-mediated free radicals in myocardial oedema and ischaemia in coronary microembolization. Circulation (1991) 84:828–884.
   PubMed Web of Science ®Google Scholar
• KITAKAZE M, HORI M, TAKASHIMA S et al.: Superoxide dismutase enhances ischaemia-induced reactive hyperemic flow and adenosine release in dogs. A role of 5t-nucleotidase activity. Circ. Res. (1992) 71:558–566.
   Google Scholar
• TAKEO S, TANONAKA K, MIYAKE K, IMAGO M: Adeninenucleotide metabolites are beneficial for recovery of cardiac contractile force after hypoxia. j Mol. Cell Cardiol. (1988) 20:187–199.
   PubMed Web of Science ®Google Scholar
• MAUSER M, HOFFMEISTER HM, NIENBER C, SCHAPER W:Influence of ribose, adenosine and `AICAR' on the rate of myocardial adenosine triphosphate synthesis during rep erfusion after coronary artery occlusion in the dog. Circ. Res. (1985) 56:220–230.
   PubMed Web of Science ®Google Scholar
• OLAFSSON, B, FORMAN MB, PUETT DW et al.: Reductionof reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothe-lium and the no-reflow phenomenon. Circulation (1987) 76:1135–1145.
   PubMed Web of Science ®Google Scholar
• DOLE VP: Insulin-like actions of ribonucleic acid,adenylic acid and adenosine. J. Biochem. Chem. (1962) 237:2758–2762.
   Google Scholar
• GREEN A, NEWSHOLME EA: Sensitivity of glucoseuptake and lipolysis of white adipoytes of the rat to insulin and effects of some metabolites. Biochem. (1979) 180:365–370.
   Google Scholar
• SCHVVABE U, SCHONHOFER PS, EBERT R: Facilitation byadenosine of the action of insulin on the accumulation of adenosine 3',5'-monophosphate, lipolysis and glucose oxidation in isolated fat cells. Eur. j Biochem. (1974) 46:536–545.
   Google Scholar
• RABERGER G, KRAUPP 0, STUHLINGER W NELL G, CHIRIKDJIAM JJ: The effects of an intracoronary infusion of adenosine on cardiac performance, blood supply and myocardial metabolism in dogs. Pflagers Arch. (1970) 317:20–34.
   PubMedGoogle Scholar
• MAINVVARING RD, MENTZER RM, JR.: Effects of dipyrida-mole on myocardial glucose uptake in the newborn lamb. J. Surg. Res. (1986) 40:528–533.
   Google Scholar
• MASHAFFEY K, PUMA JA, BARBAGELATA A et al.: Doesadenosine in conjugation with thrombosis reduce infarct size? Results from the controlled, randomized AMISTAD Trial. Circulation (1997) 6:1–206–1–207.
   Google Scholar
• NAKAYAMA H, NANTO S, PHARA T et al.: Intracoronary administration of ATP combined with direct PTCA reduces the size of myocardial infarction?: Co-operative Osaka Adenosine Trial for Acute Myocar-dial Infarction. J. Am. Coll Cardiol (1999) 33:376A. Abstract.
   Google Scholar
• IGUCHI N, NAGASHIMA H, KAWANA M: Adenosine inhibits transcription of endothelin-1 gene in endothelial cells. Circulation (1996) 94:2. Abstract.
   Google Scholar
• WILCOX CS, WELCH WJ, SCHREINER GF, BELARDINELLI L: Natriuretic and diuretic actions of a highly selective adenosine Ai receptor antagonist. J. Am. Soc. Nephrol (1999) 10:714–720.
   PubMed Web of Science ®Google Scholar
• FUNAYA H, KITAKAZE M, NODE K, MINAMINO T, KOMAMURA K, HORI M: Plasma adenosine levels increase in patients with chronic heart failure. Circula-tion (1997) 95:1363–1365.
   PubMed Web of Science ®Google Scholar
• KITAKAZE M, FUNAYA H, MINAMINO T et al.: A new strategy for the treatment of chronic heart failure: elevation of plasma adenosine levels. Cardiovasc. Drug Ther. (1998) 12:307–309.
   PubMed Web of Science ®Google Scholar
• ROSEMEYER RB, HARDEN FA, VARELA JI, HARRISON GJ, WILLIS RJ: Age-related changes in adenosine in rat coronary resistance vessels. Gen. Pharmacol (1999) 32:35–40.
   PubMedGoogle Scholar
• GAO F, CHRISTOPHER TA, LOPEZ BL, FRIEDMAN E, CAI G, MA XL: Mechanism of decreased adenosine protec-tion in reperfusion injury of aging rats. Am. J. Physiol (2000) 279:H329–H338.
   Web of Science ®Google Scholar
• HARAM S, CARRIERO D, SEAMAN C, PIOMELLI S: The mechanism of decline of age-dependent enzymes in the red blood cell. Enzyme (1991) 45:47–53.
   PubMedGoogle Scholar
• HINSCHEN AK, ROSE'MEYER RB, HEADRICK JP: Age-related changes in A(1)-adenosine receptor-mediated bradycardia. Am. J. Physiol. Heart (2000) 278:H789–H795.
   PubMed Web of Science ®Google Scholar